Ticker
NKTRCompany Name
NEKTAR THERAPEUTICSSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 438.57M | $ 314K | $ 0 | -0.07% |
3/31/2025 | $ 109.55M | $ 122K | $ 0 | -0.11% |
12/31/2024 | $ 166.9M | $ -2.88M | $ 0 | 1.73% |
9/30/2024 | $ 258.24M | $ -2.95M | $ 0 | 1.14% |
6/30/2024 | $ 204.33M | $ -2.97M | $ 0 | 1.45% |
3/31/2024 | $ 323.18M | $ -2.97M | $ 0 | 0.92% |
12/31/2023 | $ 162.33M | $ 30K | $ 0 | -0.02% |
9/30/2023 | $ 95.39M | $ 121K | $ 0 | -0.13% |
6/30/2023 | $ 173.12M | $ 121K | $ 0 | -0.07% |
3/31/2023 | $ 141.94M | $ 570K | $ 0 | -0.4% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for NEKTAR THERAPEUTICS is calculated as follows: (-1 * CF - Equity [ $ 25.56M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 3.13B ]
(=) Payout Yield [ -0.82% ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |